Literature DB >> 16522712

The Son-Rise Program intervention for autism: prerequisites for evaluation.

K R Williams1.   

Abstract

With increasing availability of interventions for children with autism, it is important that these are backed by rigorous evaluation data that have high levels of ecological validity. To achieve this, a key prerequisite for any evaluation is to gather data on typical consumers and typical implementation patterns of the intervention. This study collected such data longitudinally in relation to the Son-Rise Program, a home-based parent-run intervention for autism. Questionnaires and interview data on family demographics, implementation patterns, and perceived treatment fidelity were gathered three times over the course of a year from families who had attended a Son-Rise initial training course. Although it proved possible to produce a profile of intervention use, findings indicated that the programme is not always implemented as it is typically described in the literature. The study also highlighted methodological challenges likely to be encountered in any future evaluation of this and similar interventions for autism.

Entities:  

Mesh:

Year:  2006        PMID: 16522712     DOI: 10.1177/1362361306062012

Source DB:  PubMed          Journal:  Autism        ISSN: 1362-3613


  3 in total

1.  Applied behavior analysis programs for autism: sibling psychosocial adjustment during and following intervention use.

Authors:  Katie R Cebula
Journal:  J Autism Dev Disord       Date:  2012-05

Review 2.  Virtual Reality Technology as an Educational and Intervention Tool for Children with Autism Spectrum Disorder: Current Perspectives and Future Directions.

Authors:  Minyue Zhang; Hongwei Ding; Meri Naumceska; Yang Zhang
Journal:  Behav Sci (Basel)       Date:  2022-05-10

3.  Use of alternative communication with pictures for outpatient periodontal treatment in fragile X syndrome patients.

Authors:  Rafael Ferreira; Adriana Gledys Zink; Paulo Sérgio da Silva Santos
Journal:  J Indian Soc Periodontol       Date:  2020-09-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.